UB Paderborn / Katalog / Suche / in CDI

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial

The lancet oncology, 2014, Vol.15 (1), p.59-68

2014

Volltextzugriff (PDF)

Differences in cancer survival by sex: a population-based study using cancer registry data

Cancer causes & control, 2018-11, Vol.29 (11), p.1059-1071

2018

Volltextzugriff (PDF)

High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies

BMC cancer, 2008-05, Vol.8 (1), p.142-142, Article 142

2008

Volltextzugriff (PDF)

Reducing Artifactual EGFR T790M Mutations in DNA from Formalin-Fixed Paraffin-Embedded Tissue by Use of Thymine-DNA Glycosylase

Clinical chemistry (Baltimore, Md.), 2017-09, Vol.63 (9), p.1506-1514

2017

Volltextzugriff (PDF)

The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer

PloS one, 2013-07, Vol.8 (7), p.e67876-e67876

2013

Volltextzugriff (PDF)

A phase II clinical trial of the Vascular Disrupting Agent BNC105P as second line chemotherapy for advanced Malignant Pleural Mesothelioma

Lung cancer (Amsterdam, Netherlands), 2013-09, Vol.81 (3), p.422-427

2013

Volltextzugriff (PDF)

Lung cancer in Asian women and health system implications for Australia

The lancet oncology, 2017-12, Vol.18 (12), p.1570-1571

2017

Volltextzugriff (PDF)

Mannan-MUC1–Pulsed Dendritic Cell Immunotherapy: A Phase I Trial in Patients with Adenocarcinoma

Clinical cancer research, 2006-02, Vol.12 (3), p.869-877

2006

Volltextzugriff (PDF)

Rarity of AKT1 and AKT3 E17K mutations in squamous cell carcinoma of lung

Cell cycle (Georgetown, Tex.), 2010-11, Vol.9 (21), p.4411-4412

2010

Volltextzugriff (PDF)

Health-Related Quality of Life and Utility in Patients with Advanced Non–Small-Cell Lung Cancer: A Prospective Cross-Sectional Patient Survey in a Real-World Setting

Journal of thoracic oncology, 2013-08, Vol.8 (8), p.997-1003

2013

Volltextzugriff (PDF)

High Impact of 18F-FDG-PET on Management and Prognostic Stratification of Newly Diagnosed Small Cell Lung Cancer

Molecular imaging and biology, 2010-08, Vol.12 (4), p.443-451

2010

Volltextzugriff (PDF)

NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2020-08, Vol.146, p.154-159

2020

Volltextzugriff (PDF)

Sunvozertinib, a selective EGFR inhibitor for previously treated non-small cell lung cancer with EGFR exon 20 insertion mutations

Cancer discovery, 2022-07, Vol.12 (7), p.1676-1689

2022

Volltextzugriff (PDF)

Detection of the transforming AKT1 mutation E17K in non-small cell lung cancer by high resolution melting

BMC research notes, 2008-05, Vol.1 (1), p.14-14, Article 14

2008

Volltextzugriff (PDF)

Lung cancer in 2016: immunotherapy comes of age

The lancet respiratory medicine, 2016-12, Vol.4 (12), p.947-949

2016

Volltextzugriff (PDF)

Impact of Radiotherapy on the Efficacy and Toxicity of anti-PD-1 Inhibitors in Metastatic NSCLC

Clinical lung cancer, 2021-05, Vol.22 (3), p.e425-e430

2021

Volltextzugriff (PDF)

A critical re-assessment of DNA repair gene promoter methylation in non-small cell lung carcinoma

Scientific reports, 2014-02, Vol.4 (1), p.4186-4186, Article 4186

2014

Volltextzugriff (PDF)

Lung cancer in Victoria: are we making progress?

Medical journal of Australia, 2013-11, Vol.199 (10), p.674-679

2013

Volltextzugriff (PDF)

Credentialing of vertebral stereotactic ablative body radiotherapy in a multi-centre trial

Physica medica, 2020-04, Vol.72, p.16-21

2020

Volltextzugriff (PDF)

Relationship of Hepatic Functional Imaging to Irinotecan Pharmacokinetics and Genetic Parameters of Drug Elimination

Journal of clinical oncology, 2006-09, Vol.24 (26), p.4228-4235

2006

Volltextzugriff (PDF)

Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab

Neuro-oncology (Charlottesville, Va.), 2010-02, Vol.12 (2), p.212-215

2010

Volltextzugriff (PDF)

Correction to: Differences in cancer survival by sex: a population-based study using cancer registry data

Cancer causes & control, 2018-11, Vol.29 (11), p.1071-1071

2018

Volltextzugriff (PDF)

Do ethnic patients report longer lung cancer intervals than Anglo‐Australian patients?: Findings from a prospective, observational cohort study

European journal of cancer care, 2021-11, Vol.30 (6), p.e13492-n/a

2021

Volltextzugriff (PDF)

A phase II study of liposomal daunorubicin, in combination with cyclophosphamide, vincristine and prednisolone, in elderly patients with previously untreated aggressive non-Hodgkin lymphoma

Leukemia & lymphoma, 2008-01, Vol.49 (5), p.924-931

2008

Volltextzugriff (PDF)

Digital PCR of Genomic Rearrangements for Monitoring Circulating Tumour DNA

Advances in experimental medicine and biology, 2016, Vol.924, p.139-146

2016

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial

Differences in cancer survival by sex: a population-based study using cancer registry data

High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies

Reducing Artifactual EGFR T790M Mutations in DNA from Formalin-Fixed Paraffin-Embedded Tissue by Use of Thymine-DNA Glycosylase

The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer

A phase II clinical trial of the Vascular Disrupting Agent BNC105P as second line chemotherapy for advanced Malignant Pleural Mesothelioma

Lung cancer in Asian women and health system implications for Australia

Mannan-MUC1–Pulsed Dendritic Cell Immunotherapy: A Phase I Trial in Patients with Adenocarcinoma

Rarity of AKT1 and AKT3 E17K mutations in squamous cell carcinoma of lung

Health-Related Quality of Life and Utility in Patients with Advanced Non–Small-Cell Lung Cancer: A Prospective Cross-Sectional Patient Survey in a Real-World Setting

High Impact of 18F-FDG-PET on Management and Prognostic Stratification of Newly Diagnosed Small Cell Lung Cancer

NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer

Sunvozertinib, a selective EGFR inhibitor for previously treated non-small cell lung cancer with EGFR exon 20 insertion mutations

Detection of the transforming AKT1 mutation E17K in non-small cell lung cancer by high resolution melting

Lung cancer in 2016: immunotherapy comes of age

Impact of Radiotherapy on the Efficacy and Toxicity of anti-PD-1 Inhibitors in Metastatic NSCLC

A critical re-assessment of DNA repair gene promoter methylation in non-small cell lung carcinoma

Lung cancer in Victoria: are we making progress?

Credentialing of vertebral stereotactic ablative body radiotherapy in a multi-centre trial

Relationship of Hepatic Functional Imaging to Irinotecan Pharmacokinetics and Genetic Parameters of Drug Elimination

Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab

Correction to: Differences in cancer survival by sex: a population-based study using cancer registry data

Do ethnic patients report longer lung cancer intervals than Anglo‐Australian patients?: Findings from a prospective, observational cohort study

A phase II study of liposomal daunorubicin, in combination with cyclophosphamide, vincristine and prednisolone, in elderly patients with previously untreated aggressive non-Hodgkin lymphoma

Digital PCR of Genomic Rearrangements for Monitoring Circulating Tumour DNA

Suchergebnisse filtern